EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Impact of sex hormones on development and progression in NEN: a new therapeutic target?

Roberta Modica iD, Alessia Liccardi, Elena Zago, Nevena Mikovic, Franz Sesti, Sofia Ballarini, Renata Simona Auriemma, Annamaria Colao

Endocrine-Related Cancer · 01.09.2025 · 32 (9)

DOI: 10.1530/erc-25-0164 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, online erschienen am 16.09.2025. Verfasst von Roberta Modica und 7 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy. Hauptthemen laut MEDLINE: Gonadal Steroid Hormones, Neuroendocrine Tumors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine neoplasms (NEN) are a rare and heterogeneous group of malignancies with rising incidence, requiring multidisciplinary and personalized management. Sex is emerging as a crucial factor in NEN development and progression. Genetic, epigenetic, and hormonal mechanisms have been proposed as potential contributors influencing treatment response and prognosis, but an in-depth analysis of the role of sex hormones and their receptors in NEN is still lacking. This review aims to analyze the impact of sex hormones and their receptors in sporadic NEN to provide potential therapeutic targets in the context of precision medicine. An overview of current preclinical and clinical evidence focused on different primary NEN, including gastroenteropancreatic, lung, prostate, and medullary thyroid cancers, focusing on estrogen, progesterone, and androgen receptors, has been made to clarify their role in NEN. Variable and conflicting results emerged across different primaries. Progesterone receptors appear to play a pivotal role in pancreatic and lung NEN, while estrogen receptors are more frequently involved in small intestine NEN and medullary thyroid carcinoma, suggesting a possible role in metastatic spread. Further studies are required to increase knowledge of the underlying mechanism of sex differences in NEN to define potential therapeutic targets for personalized care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gonadal Steroid HormonesNeuroendocrine TumorsHumansAnimalsDisease ProgressionFemaleMale

Stichwörter der Autor:innen

androgen receptorestrogen receptorneuroendocrine neoplasmprogesterone receptorrisk factorsex differencesex hormones

Substanzen

Gonadal Steroid Hormones

Autor:innen und Institutionen

  • Endocrinology, Diabetology and Andrology Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
  • Department of Endocrinology, Careggi University Hospital, Florence, Italy.
  • Endocrinology Unit Sant'Andrea Hospital, ENETS Centre of Excellence, Sapienza University of Rome, Rome, Italy.
  • Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital, Milan, Italy.

ORCID-Profile: Roberta Modica

Zitieren

APA

Modica, R., Liccardi, A., Zago, E., Mikovic, N., Sesti, F., Ballarini, S., Auriemma, R. S., & Colao, A. (2025). Impact of sex hormones on development and progression in NEN: a new therapeutic target?. Endocrine-Related Cancer, 32(9). https://doi.org/10.1530/erc-25-0164

Vancouver

Modica R, Liccardi A, Zago E, Mikovic N, Sesti F, Ballarini S, et al. Impact of sex hormones on development and progression in NEN: a new therapeutic target?. Endocrine-Related Cancer. 2025;32(9). doi:10.1530/erc-25-0164

BibTeX
@article{Modica2025,
  author = {Modica, Roberta and Liccardi, Alessia and Zago, Elena and Mikovic, Nevena and Sesti, Franz and Ballarini, Sofia and Auriemma, Renata Simona and Colao, Annamaria},
  title = {Impact of sex hormones on development and progression in NEN: a new therapeutic target?},
  journal = {Endocrine-Related Cancer},
  year = {2025},
  volume = {32},
  number = {9},
  doi = {10.1530/erc-25-0164}
}
Kostenlos starten →